Bioorganic and Medicinal Chemistry Letters p. 4204 - 4209 (2008)
Update date:2022-08-03
Topics:
Shah, Unmesh
Lankin, Claire M.
Boyle, Craig D.
Chackalamannil, Samuel
Greenlee, William J.
Neustadt, Bernard R.
Cohen-Williams, Mary E.
Higgins, Guy A.
Ng, Kwokei
Varty, Geoffrey B.
Zhang, Hongtao
Lachowicz, Jean E.
SCH 58261 is a reported adenosine A2A receptor antagonist which is active in rat in vivo models of Parkinson's Disease upon ip administration. However, it has poor selectivity versus the A1 receptor and does not demonstrate oral activity. Quinoline analogs have improved upon the selectivity and pharmacokinetics of SCH 58261, but were difficult to handle due to poor aqueous solubility. We report the design and synthesis of fused heterocyclic analogs of SCH 58261 with aqueous solubility as well as improved A2A receptor binding selectivity and pharmacokinetic properties. In particular, the tetrahydronaphthyridine 4s has excellent A2A receptor in vitro binding affinity and selectivity, is active orally in a rat in vivo model of Parkinson's Disease, and has aqueous solubility of 100 μM at physiological pH.
View Morewebsite:http://www.sjc.com.tw
Contact:(886) 2-2396-6223
Address:14Fl., No. 99. Sec. 2, Jen Ai Road
Contact:886 2 2541 0022
Address:8 Fl., No. 11, Sec. 1, Chung Shan North Rd., Taipei, Taiwan R.O.C.
Contact:+8618766299236
Address:ROOM808, BUILDING2,NO.230 SHEN ZHEN ROAD, LAOSHAN DISTRICT
Jiaxing Carry Bio-Chem Technology Co.,Ltd
website:http://www.carrybiotech.com
Contact:0573-82788958
Address:Add.Fl 3th, Pharm Vally,Kaichuang Rd, Xiuzhou District, Jiaxing, Zhejiang,314031,China
Beijing Tianjia Chemical Science & Technology Co.,Ltd
Contact:86-0550-2392698
Address:No.388, Shiliang Road (East),
Doi:10.1002/jhet.5570240504
(1987)Doi:10.1134/S1070363215070075
(2015)Doi:10.1039/jr9510001888
(1951)Doi:10.1016/j.ejmech.2015.02.037
(2015)Doi:10.1021/jm00163a015
(1990)Doi:10.1002/hlca.19880710709
(1988)